Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma
Blood (2008)
  • Aj ay K Gopal, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Andrei Shustov, Fred Hutchinson Cancer Research Center
  • Stephen Petersdorf, Fred Hutchinson Cancer Research Center
  • Ted Gooley, Fred Hutchinson Cancer Research Center
  • Jasmine T. Daniels, Fred Hutchinson Cancer Research Center
  • Mitchell Garrison, Fred Hutchinson Cancer Research Center
  • George Gjerset, Fred Hutchinson Cancer Research Center
  • Matthew Lonergan, Fred Hutchinson Cancer Research Center
  • Anne Murphy, Fred Hutchinson Cancer Research Center
  • Julie Smith, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
November 16, 2008
Citation Information
Aj ay K Gopal, Oliver W. Press, Andrei Shustov, Stephen Petersdorf, et al.. "A Prospective Multicenter Phase II Study by the Puget Sound Oncology Consortium (PSOC) of Gemcitabine (G), Carboplatin (C), Dexamethasone (D), and Rituximab (R) in Patients with Relapsed/Refractory Lymphoma" Blood Vol. 112 Iss. 11 (2008) p. 2585 - 2585
Available at: http://works.bepress.com/john-pagel/232/